drugset / Trial / NCT03860831

Intranasal Ketamine and Midazolam Mixture for Procedural Sedation in Children With Mental Disabilities:

NCT03860831

Phase 1 Unknown 40 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindOther

Summary

Ketamine and Midazolam are well known sedative drugs that can be given through different routes such as intravenous, intramuscular, oral, rectal and intranasal route. Anesthetic staff usually prefer intravenous route but sometimes inserting venous access is difficult in uncooperative mentally disabled children. Intranasal ketamine+Midazolam can be a needless effective alternative in these vulnerable patients

Timeline

Start
2019-03-06
Primary completion
2019-06
Completion
2019-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 5 mg/kg Intranasal
Subject Midazolam Small molecule 0.2 mg/kg Intranasal

Indications

No indication recorded.